Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

DM and AA may share a common cause.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Alopecia areata involves immune response and gene changes affecting hair loss.

Early recognition and thyroid evaluation are crucial for managing diffuse alopecia areata linked to autoimmune thyroid disease.

A new AIRE gene mutation causes rare autoimmune symptoms in a Lebanese boy.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

People with alopecia areata are more likely to have other immune-related conditions.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Autoimmunity can cause both alopecia areata and idiopathic primary hypophysitis.

Autoimmune skin disorders are caused by genetic and environmental factors and are treated with various medications and preventative strategies.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

BST2 protein and certain T cells increase in early alopecia areata.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Impaired autophagy may contribute to alopecia areata.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Autoimmune-related phenomena do not affect the progression or characteristics of lichen sclerosus in women.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.